Tudor Investment Corp
LRMR icon

Tudor Investment Corp’s Larimar Therapeutics LRMR Stock Holding History

Tudor Investment Corp’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,223
Closed -$49K – 1524
2016
Q3 		$49K Sell
1,223
-29
-2% -$1.32K ﹤0.01% 1372
2016
Q2 		$90K Sell
1,252
-58
-4% -$4.58K ﹤0.01% 1524
2016
Q1 		$105K Sell
1,310
-8,004
-86% -$632K ﹤0.01% 1612
2015
Q4 		$703K Buy
9,314
+8,003
+610% +$1.29M 0.02% 660
2015
Q3 		$502K Buy
1,311
+378
+41% +$170K 0.02% 782
2015
Q2 		$388K Sell
933
-438
-32% -$183K 0.01% 942
2015
Q1 		$652K Buy
+1,371
New +$651K 0.02% 591

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Tudor Investment Corp's LRMR Position: Q4 2016 in Review

Tudor Investment Corp sold out of Larimar Therapeutics (LRMR) in Q4 2016, closing a stake of 1,223 shares — an estimated $49K sold.

Tudor Investment Corp first reported a position in LRMR in Q1 2015 and held it in 7 quarters. The position peaked at $703K in Q4 2015. 81 funds tracked by Wall St. Rank hold LRMR as of Q4 2016.

  • Tudor Investment Corp reported no remaining Larimar Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 1,223 Larimar Therapeutics shares in Q4 2016, an estimated $49K.
  • Tudor Investment Corp first reported a position in Larimar Therapeutics in Q1 2015 and held it in 7 quarters.
  • Tudor Investment Corp's Larimar Therapeutics position peaked at $703K in Q4 2015.
  • 81 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2016.

Based on Tudor Investment Corp's 13F filing for Q4 2016, filed 14 Feb 2017.